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Abstract
Introduction: Phendimetrazine is a medication currently being used to help patients with weight
loss. It shares a chemical structure with amphetamines. As such, it shares some of the same
toxicities, which can include cardiac toxicity. This case highlights this principle.
Case presentation: a 54 year old Caucasian female presented to our urgent care facility with
complaints of chest pains and other symptoms suggestive of acute coronary syndrome. Ultimately,
she was transferred to the emergency room. After evaluation there, it appeared she was having
demand ischemia from prescription diet pills
Conclusion: This case report demonstrates the potential dangers of amphetamine based diet pills.
There have been other cases of cardiomyopathies related to phendimetrazine, but it is something
that is rarely recognized in an outpatient setting. A case such as this demonstrates the importance
of obtaining a careful medication history in all patients and in recognizing diet pills with an
amphetamine base can cause cardiac toxicity.
Case presentation
A 54 year-old Caucasian female presented to our urgent
care facility complaining of nausea and vomiting, sense of
impending doom and vague chest pain radiating toward
her left side for about five hours. She never had similar
symptoms in the past. She also denied anything that
could have precipitated these symptoms. Her only past
medical history was significant for spina bifida. Her med-
ications included occasional Fiorinal (unknown dose),
Xanax 0.5 mg as needed, and Phendimetrazine (unclear
dose). Her social history was significant for smoking 1/2
pack per day cigarette use. She denied alcohol use. Family
history was non contributory. She worked from home.
Her physical exam showed a tachycardia of around 100
beats per minute, respiratory rate of 16, temperature of
98.1, and O2 saturation of 100% on room air. She was
approximately 5'7" and 145 pounds. In general, she was
an anxious appearing, diaphoretic woman in moderate
distress, she had no elevated JVD at 30 degrees, her heart
was tachycardic, but otherwise without murmur, gallops,
or rubs, her lungs were clear, abdomen soft, and she had
no peripheral edema. An EKG was checked which appears
below (figure 1). After examination, there was concern for
acute coronary syndrome (ACS). She was given nitroglyc-
erin with relief of her chest discomfort. She was also given
aspirin to chew. EMS was called and she was transferred to
a local emergency room. She was hospitalized there for
three days and after her discharge, we got permission from
her to request records. While hospitalized, she was ruled
out for ACS with negative troponins. She was also given
beta blockade which resolved her tachycardia and her T
wave changes on EKG. The next morning, she had an ade-
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areas of ischemia and an ejection fraction of 55%. She was
monitored for one more day and then discharged with
instructions to discontinue her diet pills.
Discussion
Phendimetrazine is a medication currently being used for
weight loss, with potential for illicit use. It has a similar
chemical composition of amphetamines, which is
thought to account for its clinical actions [1]. Ampheta-
mines are well recognized as an etiology of cardiac
ischemia, however phendimetrazine is more rarely
described in the literature as causing cardiac events. [2,3].
Acute effects include hyperpyrexia, mydriasis, chest pain,
arrhytmias, delirium, and, rhabdomylosis, among others
[2]. Long term use has been associated with dilated cardi-
omyopathies, some of which have resolved with discon-
tinuation of the medication [3]. In this particular case, it
appears she may have developed a demand ischemia from
the medication. It is not known how much of the drug she
was taking. Initially, she was resistant to accepting that
phendimetrazine could induce side effects, and there was
suspicion that she could have been taking more of the
drug that recommended. In addition, she was not pre-
scribed the medication and would not admit to where she
obtained it. As the public seems to have more focus on
using medications to induce weight loss, this may be a
more recognized complication and heart conditions
should likely be monitored prior to starting amphetamine
based weight loss pills.
Conclusion
Due to potentially detrimental effects of this medication,
phendimetrazine should be used cautiously in many situ-
ations. As it shares its chemical structure with ampheta-
mines, it also shares many of the side effects and the
potential for abuse/addiction. There have been other
reports in literature describing adverse outcomes from
An EKG taken from the patient while they were having chest painFigure 1
An EKG taken from the patient while they were having chest pain. It demonstrates T wave depression in lateral 
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phendimetrazine as well as other weight loss medications.
Therefore, cautious use is warranted.
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